- Featured Product
 - KD/KO Validated
 
LIFR Polyklonaler Antikörper
LIFR Polyklonal Antikörper für WB, IHC, IF/ICC, IF-P, IP, ELISA
Wirt / Isotyp
Kaninchen / IgG
Getestete Reaktivität
human, Maus und mehr (1)
Anwendung
WB, IHC, IF/ICC, IF-P, IP, ELISA
Konjugation
Unkonjugiert
Kat-Nr. : 22779-1-AP
Synonyme
Geprüfte Anwendungen
| Erfolgreiche Detektion in WB | humanes Skelettmuskelgewebe, HeLa-Zellen, humanes Plazenta-Gewebe, Maus-Skelettmuskelgewebe | 
| Erfolgreiche IP | Maus-Skelettmuskelgewebe | 
| Erfolgreiche Detektion in IHC | humanes Skelettmuskelgewebe,  humanes Nierengewebe,  humanes Plazenta-Gewebe,  Maus-Cerebellum-Gewebe,  Maus-Skelettmuskelgewebe Hinweis: Antigendemaskierung mit TE-Puffer pH 9,0 empfohlen. (*) Wahlweise kann die Antigendemaskierung auch mit Citratpuffer pH 6,0 erfolgen.  | 
| Erfolgreiche Detektion in IF-P | Maus-Cerebellum-Gewebe | 
| Erfolgreiche Detektion in IF/ICC | HeLa-Zellen | 
Empfohlene Verdünnung
| Anwendung | Verdünnung | 
|---|---|
| Western Blot (WB) | WB : 1:500-1:1000 | 
| Immunpräzipitation (IP) | IP : 0.5-4.0 ug for 1.0-3.0 mg of total protein lysate | 
| Immunhistochemie (IHC) | IHC : 1:50-1:500 | 
| Immunfluoreszenz (IF)-P | IF-P : 1:50-1:500 | 
| Immunfluoreszenz (IF)/ICC | IF/ICC : 1:200-1:800 | 
| It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
| Sample-dependent, check data in validation data gallery | |
Veröffentlichte Anwendungen
| KD/KO | See 1 publications below | 
| WB | See 16 publications below | 
| IHC | See 4 publications below | 
| IF | See 5 publications below | 
Produktinformation
22779-1-AP bindet in WB, IHC, IF/ICC, IF-P, IP, ELISA LIFR und zeigt Reaktivität mit human, Maus
| Getestete Reaktivität | human, Maus | 
| In Publikationen genannte Reaktivität | human, Hausschwein, Maus | 
| Wirt / Isotyp | Kaninchen / IgG | 
| Klonalität | Polyklonal | 
| Typ | Antikörper | 
| Immunogen | LIFR fusion protein Ag18742 | 
| Vollständiger Name | leukemia inhibitory factor receptor alpha | 
| Berechnetes Molekulargewicht | 1097 aa, 124 kDa | 
| Beobachtetes Molekulargewicht | 190 kDa, 170 kDa | 
| GenBank-Zugangsnummer | BC153096 | 
| Gene symbol | LIFR | 
| Gene ID (NCBI) | 3977 | 
| Konjugation | Unkonjugiert | 
| Form | Liquid | 
| Reinigungsmethode | Antigen-affinitätsgereinigt | 
| Lagerungspuffer | PBS with 0.02% sodium azide and 50% glycerol | 
| Lagerungsbedingungen | Bei -20°C lagern. Nach dem Versand ein Jahr lang stabil Aliquotieren ist bei -20oC Lagerung nicht notwendig. 20ul Größen enthalten 0,1% BSA. | 
Hintergrundinformationen
LIFR, also known as CD118, is a subunit of a receptor for leukemia inhibitory factor (LIF). LIF is a pleiotropic cytokine of the interleukin-6 family which affects the differentiation, survival, and proliferation of a wide variety of cells in the adult and the embryo. LIFR is the low-affinity binding chain that, together with the high-affinity converter subunit gp130, forms a high-affinity receptor complex that mediates the action of LIF. The high-affinity complex also binds a related cytokine, oncostatin M (PMID: 8999038). LIFR has also been identified as a breast cancer metastasis suppressor that functions through the HIPPO-YAP pathway (PMID: 23001183). LIFR appeared as doublets with 190 and 170 kDa (PMID: 10858440). They represented different glycosylated forms of the LIFR in different steps of protein maturation.
Protokolle
| PRODUKTSPEZIFISCHE PROTOKOLLE | |
|---|---|
| WB protocol for LIFR antibody 22779-1-AP | Protokoll herunterladen | 
| IHC protocol for LIFR antibody 22779-1-AP | Protokoll herunterladenl | 
| IF protocol for LIFR antibody 22779-1-AP | Protokoll herunterladen | 
| IP protocol for LIFR antibody 22779-1-AP | Protokoll herunterladen | 
| STANDARD-PROTOKOLLE | |
|---|---|
| Klicken Sie hier, um unsere Standardprotokolle anzuzeigen | 
Publikationen
| Species | Application | Title | 
|---|---|---|
Nat Metab LIFR regulates cholesterol-driven bidirectional hepatocyte-neutrophil cross-talk to promote liver regeneration | ||
Nat Commun A targetable LIFR-NF-κB-LCN2 axis controls liver tumorigenesis and vulnerability to ferroptosis.
  | ||
Clin Transl Med Aptamer-SH2 superbinder-based targeted therapy for pancreatic ductal adenocarcinoma. | ||
Hum Mol Genet Mutations in the leukemia inhibitory factor receptor (LIFR) gene and Lifr deficiency cause urinary tract malformations. | ||
J Exp Clin Cancer Res miR-589 promotes gastric cancer aggressiveness by a LIFR-PI3K/AKT-c-Jun regulatory feedback loop. | 
Rezensionen
The reviews below have been submitted by verified Proteintech customers who received an incentive for providing their feedback.
FH Clarisse (Verified Customer) (12-12-2022)  | Low signal, regardless of the method of fixation. 
  | 

















